LNP Technology definition

LNP Technology means any Technology that claims, embodies or incorporates delivery systems (and components thereof) based on or incorporating LNPs.
LNP Technology means the Patent Rights and Know-How Covering the Licensed LNP.
LNP Technology means the intellectual property (other than Protiva Patents) covering nucleic acid delivery technology directed to (i) the composition of matter of Lipid Nanoparticles, (ii) the method of use of Lipid Nanoparticles, or (iii) the method of manufacturing Lipid Nanoparticles (plus or minus encapsulated drug), in each case, Controlled by Protiva.

Examples of LNP Technology in a sentence

  • Alnylam has a long history of licensing or offering to license to third parties its intellectual property, including the Alnylam LNP Technology and the GalNAc Technology.

  • Over a decade ago, Alnylam scientists solved these pressing issues by inventing a new class of non-natural LNPs comprising a cationic lipid with biodegradable groups ( i.e., the Alnylam LNP Technology).

  • The United States Patent Office recognized Alnylam’s inventive work, issuing United States Patent No. 11,246,933 (the “’933 Patent”) that protects the Alnylam LNP Technology.

  • Under the Development and Option Agreement, the Company may reserve up to three specified targets (“Reserved Targets”) for development of therapeutic products related to such targets, using the Acuitas LNP Technology.

  • In the April 28, 2014 meeting, Alnylam presented a detailed PowerPoint disclosing Alnylam’s LNP Technology and how those LNPs could be used for developing RNA-based pharmaceuticals.


More Definitions of LNP Technology

LNP Technology means the Intellectual Property directed to (a) the composition of matter of LNPs, (b) the method of use of LNPs, (c) the method of manufacturing LNPs, and/or (d) the physical characteristics of LNPs, including [***], in each case, Controlled by Arbutus or any of its Affiliates at any time during the Term.
LNP Technology means Patent Rights and Know-How covering an LNP system (i.e. a lipid nanoparticle system which is used to formulate and deliver mRNA), as further defined in Exhibit 1.111 hereto.
LNP Technology means, collectively, the Company’s proprietary nucleic acid delivery platform based upon LNP technology and GalNac Technology. LNP Trademarks has the meaning ascribed to such term in Section 2.1(a)(i). LNP Trade Secrets has the meaning ascribed to such term in Section 2.1(b)(ii).
LNP Technology means lipid nanoparticles, components of lipid nanoparticles, and methods of making and using lipid nanoparticles. For example, the LNP technology includes (i) LNP related compositions of matter (e.g., LNPs, lipids and other components of the LNPs, and formulations including LNP or the LNP with a Payload), (ii) the physical characteristics of LNPs, including the lipid or non-lipid components of LNPs, or (iii) lipid ratios (e.g., ratios of the lipid components within a formulation or LNP).
LNP Technology means Technology that claims, embodies or incorporates delivery systems (and components thereof) based on or incorporating lipid nanoparticles (LNP). 1.30 "LNP Technology Patent(s)" means Patents comprised in the Acuitas LNP Technology, including any future Patent which will become part of the Acuitas LNP Technology during the Term and further including Acuitas' rights in the Jointly Owned Patents, unless otherwise set forth herein. 1.31 "Losses" has the meaning set forth in Section 9.6(a). 1.32 “Major Market Countries” means Canada, United States, Japan, France, Germany, Spain, Italy, or United Kingdom. 1.33 "mRNA Construct" [***] 1.34 "mRNA Technology" means Technology that claims, embodies or incorporates expression systems (and components thereof), based on or incorporating mRNA. 1.35 "Milestones" means the milestones payable pursuant to Section 4. 1.36 "Milestone Event" has the meaning set forth in Section 4.1. 1.37 "Milestone Payment" has the meaning set forth in Section 4.1.
LNP Technology means any Technology that claims, embodies or incorporates delivery systems (and components thereof) based on or incorporating LNPs. NON-EXCLUSIVE LICENSE AGREEMENT BETWEEN ACUITAS THERAPEUTICS, INC. AND OMEGA THERAPEUTICS, INC. MYC EXECUTION COPY CERTAIN CONFIDENTIAL INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED
LNP Technology has the meaning set forth in the License Agreement.